Cargando…
Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model
The deubiquitinase cylindromatosis (CYLD) is a well-known tumor suppressor, found to be down regulated in many cancer types including breast cancer, colon carcinoma and malignant melanoma. CYLD is suppressed in human melanoma cells by the transcriptional repressor SNAIL1 leading to an increase of th...
Autores principales: | de Jel, Miriam Martha, Schott, Mandy, Lamm, Susanne, Neuhuber, Winfried, Kuphal, Silke, Bosserhoff, Anja-Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779913/ https://www.ncbi.nlm.nih.gov/pubmed/31591386 http://dx.doi.org/10.1038/s41389-019-0169-4 |
Ejemplares similares
-
Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
por: Schott, Mandy, et al.
Publicado: (2022) -
Selenium-binding protein 1 is down-regulated in malignant melanoma
por: Schott, Mandy, et al.
Publicado: (2018) -
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009) -
UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017) -
HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth
por: Liebig, Janika K., et al.
Publicado: (2020)